BLFS
BioLife Solutions IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$930.74M
P/E Ratio
—
EPS
$-0.25
Beta
2.00
52W High
$29.62
52W Low
$17.86
50-Day MA
$21.16
200-Day MA
$23.86
Dividend Yield
—
Profit Margin
-4.78%
Forward P/E
169.49
PEG Ratio
15.09
About BioLife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the gene and cell therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company is headquartered in Bothell, Washington.
Fundamentals
| Revenue (TTM) | $96.21M |
| Gross Profit (TTM) | $62.12M |
| EBITDA | $3.61M |
| Operating Margin | -0.32% |
| Return on Equity | -3.37% |
| Return on Assets | -0.17% |
| Revenue/Share (TTM) | $2.02 |
| Book Value | $7.72 |
| Price-to-Book | 2.53 |
| Price-to-Sales (TTM) | 9.67 |
| EV/Revenue | 9.05 |
| EV/EBITDA | 70.89 |
| Quarterly Earnings Growth (YoY) | -13.90% |
| Quarterly Revenue Growth (YoY) | 63.90% |
| Shares Outstanding | $48.30M |
| Float | $40.53M |
| % Insiders | 2.63% |
| % Institutions | 106.27% |
Analyst Ratings
Consensus ($32.40 target)
1
Strong Buy9
BuyData last updated: 4/7/2026